Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SIRIO Pharma has reported record revenues in the APAC (excluding China) region, with construction set to begin on a major new manufacturing facility in Thailand in Q4 2025. Growth has been driven by rising demand across Southeast Asia, with key ...
read more
Orgenesis it has entered into a Collaboration Agreement with Educell, a European cell therapy company.
read more
Friday, December 04, 2020
Catalent has entered into a commercial supply agreement with Blueprint Medicines following FDA approval of GAVRETO.
read more
Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL), extending both ...
read more
Tuesday, December 19, 2023
Elligo Health Research® has recently undergone a leadership transition, with the company's founder and former CEO, John Potthoff, Ph.D., taking on the role of Chairman. Stepping into the position of CEO is Barry Simms, formerly the Chief Operating ...
read more
Wednesday, February 03, 2016
Eleven Biotherapeutics and Albumedix have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin® albumin variant assets.
read more
H.E.L Group (H.E.L), a developer and manufacturer of laboratory tools for process optimization, safety, and scale-up, announced that it has expanded its operations in North America, with the establishment of a West Coast hub in California, and a ...
read more
Exothera has launched its nucleic acids service offering, powered by their continuous-batch RNA production platform, Ntensify™. Developed by Exothera sister company Quantoom Biosciences, the Ntensify™ platform fast-tracks the production of higher ...
read more
SRI International has been awarded a contract of up to $19.8 million from the National Cancer Institute (NCI) PREVENT Cancer Preclinical Drug Development Program to support the development of potential cancer preventive agents or vaccines.
read more
Monday, December 17, 2018
Incyte and Innovent Biologics announced that the companies have entered into an agreement for three clinical-stage product candidates: pemigatinib, itacitinib and parsaclisib.
read more
Wednesday, October 31, 2018
Capua BioServices has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.
read more
Bellwyck has announced the completion of the company’s three-pronged strategic press-acquisition initiative.
read more
Thursday, January 08, 2026
LabConnect announced the opening of its new corporate headquarters in Raleigh, North Carolina, strengthening its footprint in the rapidly growing Research Triangle region, a leading center for Contract Research Organizations (CROs), biotechnology, ...
read more
Wednesday, December 11, 2013
Celerion is pleased to announce the appointment of John Horkulak as Executive Director, Eurasian Site Operations. Mr. Horkulak will lead the efforts to further expand the company’s early phase patient capabilities in Europe and Asia.
read more
Sterling Pharma Solutions announced that it has expanded its bioanalytical services offering at its Deeside, UK site, which is the company’s dedicated facility for antibody-drug conjugates (ADCs).
read more